Shang-Wen Chen Selected Research

Pharyngeal Neoplasms

9/2017	Immunohistochemical biomarkers and volumetric parameters for predicting radiotherapy-based outcomes in patients with p16-negative pharyngeal cancer.
4/2017	Correlation of pretreatment 18F-FDG PET tumor textural features with gene expression in pharyngeal cancer and implications for radiotherapy-based treatment outcomes.
12/2016	Immunohistochemical overexpression of hypoxia-induced factor 1α associated with slow reduction in 18fluoro-2-deoxy-D-glucose uptake for chemoradiotherapy in patients with pharyngeal cancer.
5/2014	Pretreatment (18)F-FDG PET/CT in whole-body total lesion glycolysis to predict survival in patients with pharyngeal cancer treated with definitive radiotherapy.
8/2012	Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy.
1/2012	Pretreatment maximal standardized uptake value of the primary tumor predicts outcome to radiotherapy in patients with pharyngeal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shang-Wen Chen Research Topics

Disease

21	Neoplasms (Cancer) 01/2021 - 05/2003
14	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2019 - 05/2003
7	Head and Neck Neoplasms (Head and Neck Cancer) 02/2015 - 09/2010
6	Pharyngeal Neoplasms 09/2017 - 01/2012
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 04/2014
5	Hypopharyngeal Neoplasms 01/2018 - 11/2006
4	Rectal Neoplasms (Rectal Cancer) 12/2021 - 02/2009
4	Breast Neoplasms (Breast Cancer) 01/2020 - 09/2014
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2019 - 01/2008
3	Liver Neoplasms (Liver Cancer) 01/2019 - 04/2014
2	Adenocarcinoma 06/2020 - 06/2019
2	Neoplasm Metastasis (Metastasis) 12/2019 - 11/2008
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 08/2015
2	Esophageal Neoplasms (Esophageal Cancer) 03/2014 - 12/2013
2	Lymphoma (Lymphomas) 05/2013 - 10/2010
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2012 - 10/2012
2	Carcinoma (Carcinomatosis) 09/2003 - 05/2003
1	Nasopharyngeal Carcinoma 06/2022
1	Fibrosis (Cirrhosis) 04/2021
1	Cardiomegaly (Heart Hypertrophy) 04/2021
1	Obesity 04/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2018
1	Seroma 03/2017
1	Hypoxia (Hypoxemia) 12/2016
1	Thrombosis (Thrombus) 07/2016
1	Liver Diseases (Liver Disease) 07/2016
1	Necrosis 02/2015
1	Fatigue 09/2014
1	Body Weight (Weight, Body) 01/2014
1	Pneumonia (Pneumonitis) 08/2013
1	Composite Lymphoma 05/2013
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 05/2013
1	Inflammation (Inflammations) 04/2013
1	Brain Neoplasms (Brain Tumor) 10/2012
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 07/2012
1	Residual Neoplasm 11/2007
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2005
1	Radiation Injuries (Radiation Sickness) 10/2004

Drug/Important Bio-Agent (IBA)

8	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2019 - 09/2010
5	Biomarkers (Surrogate Marker)IBA 06/2020 - 04/2017
2	Biological ProductsIBA 09/2017 - 09/2010
2	Cisplatin (Platino)FDA LinkGeneric 06/2014 - 12/2006
1	Ubiquitin-Conjugating EnzymesIBA 06/2022
1	Etanercept (Enbrel)FDA Link 04/2021
1	PalmitatesIBA 04/2021
1	BilirubinIBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	AlbuminsIBA 01/2021
1	neratinibIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Lapatinib (GW572016)FDA Link 01/2020
1	Loperamide (Imodium)FDA LinkGeneric 01/2020
1	Capecitabine (Xeloda)FDA Link 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	LigandsIBA 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2017
1	Cytidine Triphosphate (CTP)IBA 07/2016
1	Sorafenib (BAY 43-9006)FDA Link 04/2014
1	ErbB Receptors (EGF Receptor)IBA 10/2012
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2010
1	squamous cell carcinoma-related antigenIBA 01/2008
1	Carcinoembryonic AntigenIBA 01/2008
1	Thallium-201IBA 10/2003

Therapy/Procedure

29	Radiotherapy 01/2021 - 05/2003
17	Chemoradiotherapy 01/2021 - 12/2006
10	Brachytherapy 01/2021 - 05/2003
5	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2014 - 01/2005
4	Drug Therapy (Chemotherapy) 01/2021 - 05/2013
4	Surgical Instruments (Clip) 01/2019 - 04/2014
3	Therapeutics 04/2017 - 10/2003
3	Adjuvant Radiotherapy 03/2017 - 09/2003
2	Neoadjuvant Therapy 12/2021 - 03/2020
2	Hysterectomy 10/2004 - 09/2003
1	Subcutaneous Injections 04/2021
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Particle Accelerators 01/2019
1	Re-Irradiation 07/2016
1	Adjuvant Chemotherapy 09/2014
1	Image-Guided Radiotherapy 01/2014
1	Salvage Therapy 11/2007
1	Aftercare (After-Treatment) 11/2006